Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Term Safety of Levalbuterol vs Racemic Albuterol in Asthma
NCT00064389Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Jan 2003
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of levalbuterol in asthma (2 arms), sponsored by Sumitomo Pharma America. Primary endpoint: Incidence of post-randomization adverse events at 12 months. Started Jan 2003; status: completed.
02
Drugs
levalbuterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00064389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064389.